Progyny Inc. (NASDAQ:PGNY) does about 881.37K shares in volume on a normal day but saw 1032018 shares change hands in Friday trading. The company now has a market cap of 2.66B USD and an enterprise value of about $2.57B. Its current market price is $29.38, marking a decrease of -5.20% compared to the previous close of $30.99. The 52 week high reached by this stock is $36.50 whilst the lowest price level in 52 weeks is $13.29. The script in recent trading has seen the stock touch a high of $31.42 and a low of $29.35.
Progyny Inc. (PGNY) has a 20-day trading average at $28.35 and the current price is -19.51% off the 52-week high compared with 121.07% distance from its 52-week low. The 50-day simple moving average of the closing price is $26.50 and its 200-day simple moving average is $25.62. If we look at the stock’s price movements over the week, volatility stands at 7.12%, which decreases to 5.90% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 54.86 to suggest the stock is neutral.
6 analysts observing the Progyny Inc. (PGNY) stock have set the 12-month price targets for the company’s shares at between $30.00 and $44.00. The consensus objective for the share price is $34.60, suggesting that the stock has a potential upside of 15.09% over the period. The median price target is 12.3% away from the current levels at $33.50.
FactSet Research has provided data showing that 6 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 5 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 01, 2020 when SVB Leerink initiated the stock to “Outperform” and issued a price target of $35. SVB Leerink initiated its price target at $28.
The current price level is 4.08%, 11.52%, and 14.88% away from its SMA20, SMA50, and SMA200 respectively, with the PGNY price moving above the 50-day SMA on August 21. Progyny Inc. (PGNY) stock is down -0.94% over the week and 8.09% over the past month. Its price is 7.03% year-to-date.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.02 above consensus estimates by $0.01. The company’s next earnings report is expected on 12/02/2020, with forecasts estimating quarterly EPS at $0.04 and $0.09 for whole year. PGNY’s earnings per share are forecast to shrink by -18.20% this year and 344.40% over next year. Expected sales for next quarter are $99.5 million, which analysts say will come at $337.32 million for the current fiscal year and next year at $543.01 million. In addition, estimates put the company’s current quarterly revenue at an average of $92.24 million.
Its 12-month price target is $33.50. To reach the target analysts have set, the stock logically needs to grow 15.09 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $30.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $44.00.
Outstanding shares total 85.28M with insiders holding 20.39% of the shares and institutional holders owning 61.52% of the company’s common stock. The company has a return on investment of 8.50% and return on equity of -15.70%. The forward price to earnings ratio is 72.54. Price to book ratio is 20.99 and price to sales ratio is 9.80.
According to a U.S. Securities and Exchange Commission filing, Delaware Smid Cap Growth Fund has added its position in Progyny Inc. (PGNY) to 2,722,801 shares, mirroring a recent increase by 62.15%. Delaware Smid Cap Growth Fund added 1.04 million shares of Progyny Inc. common stock bringing its total worth to about $72.49 million at the end of recent close, SEC documents show. Delaware Smid Cap Growth Fund isn’t the only investment manager who changed stakes and is followed by ClearBridge Small Cap Growth Fund, which added 0.27 million shares to end up with 1,704,350 shares worth $45.38 million. Alger Funds – Weatherbie Speciali raise their holdings by 43.85% in the company over the course of the most recent quarter. It now holds a 1.29% position in Progyny Inc. thanks to 1.09 million shares amounting to $29.14 million.